Apollo Medical - AMEH Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.

3 equities research analysts have issued 1-year target prices for Apollo Medical's stock. Their AMEH share price forecasts range from $57.00 to $57.00. On average, they predict the company's share price to reach $57.00 in the next twelve months. This suggests a possible upside of 39.3% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.

Apollo Medical's stock was trading at $73.48 at the start of the year. Since then, AMEH stock has decreased by 44.3% and is now trading at $40.91.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our AMEH earnings forecast.

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) released its earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.35. The company had revenue of $227.12 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 15.80% and a net margin of 7.72%. During the same period in the previous year, the business posted $0.45 earnings per share.

Apollo Medical issued an update on its FY 2022 earnings guidance on Thursday, September, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.08 billion, compared to the consensus revenue estimate of $1.06 billion.

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMEH stock can currently be purchased for approximately $40.91.

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.31 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.60 on an earnings per share basis.

The company employs 1,133 workers across the globe.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at investors@apollomed.net, or via fax at 818-839-5190.